Cita APA

Yamada, I., Suzuki, F., Kamiya, N., Aoki, K., Sakurai, Y., Kano, M., . . . Kumada, H. (2012). Safety, pharmacokinetics and resistant variants of telaprevir alone for 12 weeks in hepatitis C virus genotype 1b infection. Blackwell Publishing Ltd.

Citación estilo Chicago

Yamada, I., F. Suzuki, N. Kamiya, K. Aoki, Y. Sakurai, M. Kano, H. Matsui, y H. Kumada. Safety, Pharmacokinetics and Resistant Variants of Telaprevir Alone for 12 Weeks in Hepatitis C Virus Genotype 1b Infection. Blackwell Publishing Ltd, 2012.

Cita MLA

Yamada, I., et al. Safety, Pharmacokinetics and Resistant Variants of Telaprevir Alone for 12 Weeks in Hepatitis C Virus Genotype 1b Infection. Blackwell Publishing Ltd, 2012.